Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches

Cigarette Smoking Behavior Clinical Trial

— RESIST  

Official title:

Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04812795
• Other study ID #: 843579
• Secondary ID: R01CA237670
• Status: Completed
• Phase: N/A
• Start date: September 8, 2021
• Est. completion date: June 20, 2022

Study information

• Verified date: November 2023
• Source: Abramson Cancer Center at Penn Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.

Description:

This study will recruit 2000 young adult sexual minority women (SMW), ages 18-30 years, current smokers (n = 1000) and not current smokers (n=1000). The study team will randomly assign participants to a condition in which they will be exposed to either culturally tailored anti-smoking messages or non-tailored. Participants will receive these messages at baseline and 1, 2, and 3 weeks post baseline. They will be asked to complete a follow-up survey one month post baseline. Intentions to quit smoking as well as intention (among current smokers) and intention to purchase cigarettes (among current nonsmokers) will be measured at baseline and one-month post baseline.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2214
• Est. completion date: June 20, 2022
• Est. primary completion date: May 5, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Ages 18-30

• Woman

• Identifies as a sexual minority (any sexual orientation other than heterosexual)

• Lives in the United States

• Able to take surveys in English

Exclusion Criteria:

• Under 18 or older than 30

• Men

• Heterosexual

• Lives outside the United States

• Unable to take survey in English

Related Conditions & MeSH terms

• Cigarette Smoking Behavior

Intervention

Other:
• Culturally tailored anti-smoking messages
Anti-smoking messages that are culturally tailored for sexual minority women.
• Non-culturally tailored interventions
Anti-smoking messages that are not culturally tailored for sexual minority women.

Locations

Country	Name	City	State
United States	University of Pennsylvania	Philadelphia	Pennsylvania
United States	Stanford University	Stanford	California

Sponsors (7)

Lead Sponsor	Collaborator
Abramson Cancer Center at Penn Medicine	Dana-Farber Cancer Institute, Fenway Community Health, Harvard School of Public Health (HSPH), Michigan State University, National Cancer Institute (NCI), Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Intention to Quit Smoking	Intention to quit smoking will be measured using the Burkhalter intention to quit smoking four item scale that measures readiness to cut down or quit smoking in the next 30 days at baseline and 1 month follow-up.; Participants were asked to rate 4 statements: I will make an effort to quit smoking in the next 30 days (Unlikely to Likely); I intend to quit smoking in the next 30 days (Strongly disagree to Strongly Agree); I expect to quit smoking in the next 30 days (Definitely false to Definitely true); How likely is it that you will quit smoking in the next 30 days (Unlikely to Likely). Responses ranged on 7-point Likert-like scales. Responses were summed to create a scale for intention to quit (range from 4-28).; This will only be measured among current smokers. Lowest score is 4 and highest mean score is 28. Higher scores indicate increased intention to quit smoking within the next 30 days.	Day 30
Primary	Change in Intention to Purchase Cigarettes	The Juster scale was used to measure intention to purchase cigarettes at baseline and at one-month follow-up.; Participants were asked, "How likely are you to purchase cigarettes in the next 6 months?" Responses ranged from 0=No chance, almost no chance (1 in 100) to 10=Certain, practically certain (99 in 100).; Higher values reflect higher intention to purchase.	Day 30